About US
Contact us
-
AstraZeneca to build production facility in China for COPD inhaler BreztriAstraZeneca plans to build a manufacturing facility in Qingdao, China, to produce its Breztri aerosol inhalant COPD treatment, which was recently added to the country’s National Reimbursement Drug Li2022/8/1
-
Ginkgo to acquire Zymergen for $300mGinkgo Bioworks hassigneda definitive agreement for the acquisition of biotechnology company Zymergen in an all-stock deal worth nearly $300m. According to the agreement, 5.25% of the pro forma merge2022/7/27
-
FDA accepts BLA for Sandoz’s proposed biosimilar natalizumabThe US Food and Drug Administration (FDA) hasacceptedthe biologics licence application (BLA) ofNovartissubsidiary Sandoz for natalizumab, a proposed first-ever multiple sclerosis (MS) biosimilar to r2022/7/27
-
PhexTour 2022- Jinan station successfully concluded.PhexTour Pharmaceutical PreparationTechnology Application Seminar - Jinan station, on July 22, 2022 in JinanGaoxin Zhixuan Holiday successfully concluded. In view of the impact of the epidemic, thec2022/7/22
-
Amgen partners with Fosun to bring Otezla, Parsabiv to patients in ChinaIn an effort to grow its presence in China, U.S. biotech giant Amgen has partnered with China’s Fosun Pharma to bring Otezla and Parsabiv to patients in the country. Amgen China will out-licens2022/7/20
-
WuXi debuts another high-potency API production facility in ChinaWuxi STA, a subsidiary of WuXi AppTec, continued its manufacturing expansion march with theopeningof another high-potency active pharmaceutical ingredient (HPAPI) production facility in China.2022/7/20
-
Pfizer partner CStone explores sale as US path blocked, Chinese competition heats up: BloombergA Pfizer cancer drug partner in China is considering a sale as the biotech’s commercial path in the U.S. looks uncertain and competition in its home country intensifies. CStone Pharmaceuticals2022/7/18
-
Ex-Novartis sales rep claims discrimination, retaliation led to her firing after she reported misconductA former Novartis sales representative has accused the company and two of her former supervisors of wrongfully firing her after she blew the whistle on a co-worker who allegedly falsified records.2022/7/18
-
BeiGene, Novartis' PD-1 delay; China's latest VBP; A Pfizer partner for sale?BeiGene and Novartis' PD-1 inhibitor was delayed at the FDA as the agency couldn't conduct inspections in China. Big Pharma's off-patent drugs once again lost major supply contracts in China's latest2022/7/15
-
J&J lambasts Sanofi for Zantac marketing claims just as its Icy Hot pain patch campaign faces scrutinySanofi’s legal team was handed a double whammy this week (and may want a word with its marketing team) as two of the French pharma’s products have come under fire. First up, Sanoficaught the ir2022/7/15